PL 01 - Plenary Session

Moderator(s)

• 

  Kenneth Rosenzweig, MD, FASTRO

  Icahn School of Medicine at Mount Sinai
  New York, New York, United States
• 

  Farzan Siddiqui, MD, PhD

  Henry Ford Health/Henry Ford Hospital
  Detroit, MI

Presentations:

• 1:30 PM – 1:40 PM ET

  A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505)
  

  Presenter: Matthew Poppe, MD, FASTRO – University of Utah Huntsman Cancer Institute
• 1:40 PM – 1:50 PM ET

  Discussant
  

  Discussant: Kathleen Horst, MD – Stanford University
• 1:50 PM – 2:00 PM ET

  Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer
  

  Presenter: Jason Efstathiou, MD, PhD, FASTRO – Massachusetts General Hospital
• 2:00 PM – 2:10 PM ET

  Discussant
  

  Discussant: Curtiland Deville, MD, FASTRO – Johns Hopkins University
• 2:10 PM – 2:20 PM ET

  Concurrent Chemoradiation +/- Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005
  

  Presenter: Kristin Higgins, MD – City of Hope Atlanta
• 2:20 PM – 2:30 PM ET

  Discussant
  

  Discussant: Robert Samstein, MD, PhD – Icahn School of Medicine at Mount Sinai
• 2:30 PM – 2:40 PM ET

  Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients
  

  Presenter: Sue Yom, MD, PhD, FASTRO – UCSF Bakar Precision Medicine Cancer Center
• 2:40 PM – 2:50 PM ET

  Discussant
  

  Discussant: Sewit Teckie, MD, MBA – New York City Health and Hospitals